中文 | English
Return
Total: 6 , 1/1
Show Home Prev Next End page: GO
Author:(Zongyang YU)

1.Expression of XIAP and Smac in human non-small-cell lung carcinoma(NSCLC)and the relationship with clinical significance and prognosis

Wenyuan YE ; Xuenong OUYANG ; Zongyang YU

Chinese Journal of Clinical Oncology 2014;(7):444-448

2.Effect of insulin-like growth factor 1 receptor ?-strain interrupted on lung adenoma cell line SPC-A-1

Zongyang YU ; Jian DU ; Fenghua LAN

China Oncology 2001;0(03):-

3.Influence of Chinese herbal medicine Feitai Capsule on completion or delay of chemotherapy in patients with stage IIIB/IV non-small-cell lung cancer: a randomized controlled trial.

Shuiqiu DENG ; Xuenong OUYANG ; Zongyang YU ; Xihu DAI ; Xi CHEN ; Fangzheng FANG ; Wenwu WANG ; Zhizhen LIU

Journal of Integrative Medicine 2012;10(6):635-40

4.The inhibitory effects at the α-strain of insulin-like growth factor 1 receptor on SPCA-1 and A549 lung adenocarcinoma cell lines.

Zongyang YU ; Jian DU ; Xuenong OUYANG ; Liqing YAO

Chinese Journal of Lung Cancer 2007;10(6):451-454

5.High performance liquid chromatography for determining the isofraxidin content in Feitai Capsule

Zongyang YU ; Xuenong OUYANG ; Quanshan HE ; Xihu DAI ; Guixiang ZHONG ; Jia YAN ; Zhizhen LIU

Journal of Medical Postgraduates 2004;0(01):-

6.Effects of Feitai Capsule on quality of life in patients with advanced non-small-cell lung cancer: a randomized controlled trial.

Zhizhen LIU ; Zongyang YU ; Xuenong OUYANG ; Xihu DAI ; Xi CHEN ; Zhongquan ZHAO ; Wenwu WANG ; Jie LI ; Hua TU ; Lei YE ; Yan YAN

Journal of Integrative Medicine 2009;7(7):611-5

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 6 , 1/1 Show Home Prev Next End page: GO